Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

FR 167344

Known as: FR-167344, FR167344 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Kinins, members of a family of peptides released from kininogens by the action of kallikreins, have been implicated in a variety… Expand
Is this relevant?
1999
1999
A number of biologically active peptides including bradykinin (BK) are known to elicit an unspecific, non-receptor-mediated… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Recently we reported on overcoming the species difference of our first orally active non-peptide bradykinin (BK) B2 receptor… Expand
Is this relevant?
1998
1998
It is speculated that bradykinin may play an important role in asthma. Thus, bradykinin receptor antagonists may have therapeutic… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
We describe the receptor binding and antagonistic properties of two novel nonpeptide antagonists, FR167344 (3-bromo-8-[2,6… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
1997
1997
Kinins, members of a family of peptides released from kininogens by the action of kallikreins, exhibit a variety of biological… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1997
1997
1 The effects of a novel, potent and orally active nonpeptide bradykinin B2 receptor antagonist, FR167344 (N ‐[N ‐[3 ‐[(3 ‐ bromo… Expand
Is this relevant?
1997
1997
To investigate the pathophysiological role of bradykinin and to develop a drug for inflammatory diseases, we discovered an orally… Expand
Is this relevant?